PATENT CLAIM ANALYSIS

Application Number: 15977633
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 31):
The conjugate of  claim 30 , wherein the alkylenecarbonyl is substituted with one or more substituents X 1  selected from the group consisting of alkyl, alkoxy, alkoxyalkyl, hydroxy, hydroxyalkyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, halo, haloalkyl, sulfhydrylalkyl, alkylthioalkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, carboxy, carboxyalkyl, and alkyl carboxylate.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15959110', '15606913', '14794482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7239375974128073
- 35 USC 102 Novelty (BERT): 0.5435709703397106
- Combined Prediction Score: 0.7059009347054976
- Mean Citation Score: 294.984832
- Max Citation Score: 379.33395
- Similarity Product: 253.3815512692273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test